It is known that regulatory T cell-mediated/IL-10-dependent suppression of CD8+ T cells can be blocked by removal of tumour-derived HMGB150, which is consistent with our observation that HMGB1 inhibition leads to delayed tumour growth although via an alternate mechanism. The gene discussed is CD8A; the disease is neoplasm.